PREMIXED INSULIN REGIMEN TO BASAL-BOLUS INSULIN OUTCOMES IN TYPE 2 DIABETES SUBJECTS. Int. Res. J. Pharm. 2023;14(2):40-48. doi:10.56802/enp5vh61